Abstract
Liver transplantation is the accepted mode of treatment for children with end-stage liver disease or acute liver failure. Long-term outcomes have significantly improved, and the aim of management is no longer only long-term survival, but also focuses on quality of life.
Liver transplantation in Africa faces a number of challenges including wide socioeconomic disparities, shortage of skilled medical personnel and facilities, infectious disease burden, and insecure access to and monitoring of immunosuppression. While there is a need for liver transplantation, the establishment and sustainability of transplant programs require careful planning with national government and institutional support. Appropriate training of the transplant team, development of assessment and treatment protocols, and transparent and equitable criteria for organ allocation are important to establish before embarking on a transplant program.
Establishing sustainable, self-sufficient liver transplant programs with equal access to all citizens including access to living-related liver transplantation for countries with no liver transplant programs is an important step toward curtailing transplant tourism and organ trafficking. Development of liver transplant programs has a further beneficial effect of raising the level of medical and surgical care in these countries.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akoh JJ (2011) Renal transplantation in developing countries. Saudi J Kidney Dis Transpl 22(4):637–650
Akoh JA (2012) Key issues in transplant tourism. World J Transplant 2(1):9–18
Andries S, Casamayou L, Sempoux C et al (2001) Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 72:267–272
Arora N, McKiernan PJ, Beath SV et al (2002) Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation. Pediatr Transplant 6:214–218
Bahador A, Salahi H, Nikeghbalian S et al (2009) Pediatric liver transplantation in Iran: a 9-year experience. Transplant Proc 41:2864–2867
Basso MS, Subramaniam P, Tredger M et al (2011) Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients. Pediatr Transplant 15(7):722–727
Botha JF, Spearman CW, Millar AJ et al (2000) Ten years of liver transplantation at Groote Schuur Hospital. S Afr Med J 90(9):880–883
Devictor D, Tissieres P, Bicêtre Hospital Pediatric Transplant Group (2013) Pediatric liver transplantation: where do we stand? Where we are going to? Expert Rev Gastroenterol Hepatol 7(7):629–634
El Moghazy W, Kashkoush S, O’Hali W, Abdallah K (2015) Long-term outcome after liver transplantation for hepatic schistosomiasis: a single-center experience over 15 years. Liver Transpl 21(1):96–100
Evans HM, McKiernan PJ, Kelly DA (2005) Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation. Transplantation 79:1575–1580
Falkenstein K, Flynn L, Kirkpatrick B et al (2004) Non-compliance in children post-liver transplant. Who are the culprits? Pediatr Transplant 8:233–236
Harden PN, Walsh G, Bandler N et al (2012) Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure. BMJ 1:344
Hoffmann CJ, Thio CL (2007) Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7:402–409
Huprikar S, Danziger-Isakov L, Ahn J et al (2015) Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant 15(5):1162–1172
Immunization, Vaccines and Biologicals (IVB Catalogue 2014) World Health Organization. http://www.who.int/immunization/documents/en. Accessed 28 Apr 2015
International Summit on Transplant Tourism and Organ Trafficking (2008) The declaration of Istanbul on organ trafficking and transplant tourism. Kidney Int 74:854–859
Jiménez-Rivera C, Avitzur Y, Fecteau AH et al (2004) Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatr Transplant 8(3):243–248
Kelly DA (1997) Posttransplant growth failure in children. Liver Transpl Surg 3(Suppl 1):S32–S39
Kelly DA (2006) Current issues in pediatric transplantation. Pediatr Transplant 10:712–720
Kelly D (2011) Safety and efficacy of tacrolimus in pediatric liver recipients. Pediatr Transplant 15(1):19–24
Kelly D, Wray J (2014) The adolescent liver transplant patient. Clin Liver Dis 18(3):613–632
Kelly D, Jara P, Rodeck B et al (2004) Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial. Lancet 364:1054–1061
Kerkar N, Hadzić N, Davies ET et al (1988) De-novo autoimmune hepatitis after liver transplantation. Lancet 351:409–413
Khalaf H, El-Meteini M, El-Sefi T et al (2005) Evolution of living donor liver transplantation in Egypt. Saudi Med J 26:1394–1397
Kim WR, Lake JR, Smith JM et al (2016) Liver. Am J Transplant 16(Suppl 2):69–98
Lee KH, Chun TW, Lim SG et al (2001) Risk for de novo Hepatitis B from antibody to Hepatitis B core antigen-positive donors in liver transplantation in Singapore. Liver Transpl 7:469–470
Loveland J, Britz R, Joseph C et al (2014) Paediatric liver transplantation in Johannesburg revisited: 59 transplants and challenges met. S Afr Med J 104(11):799–802
Matthews PC, Gerettic A, Gouldera PJR et al (2014) Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa. J Clin Virol 61:20–33
Mazariegos G, Shneider B, Burton B et al (2014) Liver transplantation for pediatric metabolic disease. Mol Genet Metab 111(4):418–427
McDiarmid SV (2000) Liver transplantation: the pediatric challenge. Clin Liver Dis 4(4):879–927
McDiarmid SV (2001) Management of the pediatric liver transplant patient. Liver Transplant 7(Suppl 1):S77–86
McDiarmid SV, Anand R, Lindblad AS, Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation (SPLIT) Research Group (2002) Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74:173–181
McDiarmid SV, Anand R, Martz K et al (2011) A multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver transplantation. Ann Surg 254(1):145–154
Millar AJ, Hamza AF (2012) Liver transplantation in an African setting. Semin Pediatr Surg 21(2):164–171
Millar AJ, Spearman W, McCulloch M et al (2004) Liver transplantation for children -the Red Cross Children’s Hospital experience. Pediatr Transplant 8:136–144
Muller E, White S, Delmonico F (2014) Regional perspective: developing organ transplantation in Sub-Saharan Africa. Transplantation 97(10):975–976
Neto JS, Carone E, Pugliese RP et al (2010) Modified pediatric end-stage liver disease scoring system and pediatric liver transplantation in Brazil. Liver Transpl 16:426–430
Abbud-Filho M, Al-Mousawi M, Ali Alobaidli A, et al (2008) Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul. Lancet 372:5–6
Otte JB (2004) Paediatric liver transplantation- a review based on 20 years of personal experience. Transpl Int 17:562–573
Post DJ, Douglas DD, Mulligan DC (2005) Immunosuppression in liver transplantation. Liver Transpl 11(11):1307–1314
Quak SH (2009) Liver transplantation in the developing world. Curr Opin Organ Transplant 14(5):540–543
Reding R, Gras J, Sokal E et al (2003) Steroid-free liver transplantation in children. Lancet 362:2068–2070
Reding R, Bourdeaux C, Gras J et al (2004) The paediatric liver transplantation program at the Universite catholique de Louvain. Acta Gastroenterol Belg 67:176–178
Rizvi SA, Naqvi SA (1997) Need for increasing transplant activity: a sustainable model for developing countries. Transplant Proc 29:1560–1562
Sangare L, Sombie R, Combassere AW et al (2009) Ante-natal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso. Bull Soc Pathol Exot 102:226–229
Shaw BW Jr (1989) Starting a liver transplant program. Semin Liver Dis 9:159–167
Shaw BW Jr, Gordon RD, Iwatsuki S et al (1985) Retransplantation of the liver. Semin Liver Dis 5:394–401
Sibal A, Rajasekar MR, Soin AS (1999) Liver transplantation in the developing world. Indian J Pediatr 66(Suppl 1):S120–S123
Skagen CL, Jou JH, Said A (2011) Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts – a systematic analysis. Clin Transplant 25(3):E243–E249
Spada M, Petz W, Bertani A et al (2006) Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. Am J Transplant 6(8):1913–1921
Spearman CW, McCulloch MI (2014) Challenges for paediatric transplantation in Africa. Pediatr Transplant 18(7):668–674
Spearman CWN, McCulloch M, Millar AJW et al (2006) Liver transplantation at Red Cross War Memorial Children’s Hospital. S Afr Med J 96:960–963
Spearman CW, Kahn D, Millar AJ et al (2011) Pregnancy following liver transplantation during childhood and adolescence. Pediatr Transplant 15(7):712–717
Sudan DL, Shaw BW Jr, Langnas AN (1998) Causes of late mortality in pediatric liver transplant recipients. Ann Surg 227:289–295
Ullah K, Reza S, Ahmed P et al (2008) Posttransplant infections: single centre experience from the developing world. Int J Infect Dis 12:203–214
WHO Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. http://www.who.int/hiv/pub/hepatitis/hepatitis-b-guidelines/en/. Accessed 28 Apr 2015
Wong TCL, Fung JYY, Mau Lo C (2013) Prevention of recurrent hepatitis B infection after liver transplantation. Hepatobiliary Pancreat Dis Int 12:465–472
World Health Organization Position Paper (2009) Hepatitis B vaccines. WHO Wkly Epidemiol Rec 84(40):405–420. http://www.who.int.wer. Accessed 28 Apr 2015
Zhu FC, Zhang J, Zhang XF et al (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376:895–902
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Spearman, C.W.N., Millar, A.J.W. (2018). Experience in Africa. In: Dunn, S., Horslen, S. (eds) Solid Organ Transplantation in Infants and Children. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-07284-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-07284-5_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07283-8
Online ISBN: 978-3-319-07284-5
eBook Packages: MedicineReference Module Medicine